Cardiac thrombosis, a grave medical concern, is characterized by the formation of blood clots within the cardiovascular system. This condition, with its potential to impede blood flow, poses a substantial risk to heart health, leading to severe complications like heart attacks or strokes. Underlying cardiovascular issues such as atrial fibrillation, myocardial infarction, or heart valve disorders are often linked to the development of cardiac thrombosis. Certain lifestyle factors, including obesity, smoking, and a sedentary way of life, can increase susceptibility to this condition. Early detection and prompt intervention are vital in managing cardiac thrombosis. Treatment strategies typically involve the use of anticoagulant medications to prevent further clot formation and minimize the risk of adverse events. Regular monitoring by healthcare professionals is essential to tailor an effective management plan, underscoring the importance of lifestyle adjustments and ongoing medical care to reduce the likelihood of recurrence.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States